OraSure Technologies | OSUR - Net Income


OraSure Technologies reported $-19.29M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agilent USD 362M 23M Jun/2026
AngioDynamics USD -6.35M 4.55M Sep/2025
Becton, Dickinson and Co. USD 377M 688M Jun/2026
Bio Techne USD 51.05M 13.04M Mar/2026
Bio-Rad Laboratories USD 371.4M 898.5M Jun/2026
Bruker USD -62.9M 66.4M Jun/2026
Cerus USD -20.92M 17.98M Dec/2024
Charles River Laboratories USD -1.48M 13.36M Jun/2026
Danaher USD 870M 159M Jun/2026
Dentsply International USD 37M 47M Jun/2026
Dexcom USD 249.1M 49.6M Jun/2026
Illumina USD 207M 73M Jun/2026
Integra LifeSciences USD 4.48M 9.1M Jun/2026
Intuitive Surgical USD 818.1M 3.4M Jun/2026
IQVIA Holdings USD 256M 18M Jun/2026
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Mettler Toledo International USD 232.9M 63.44M Jun/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Quidel USD -92.9M 1.1M Jun/2026
Repligen USD 5.01M 3.32M Jun/2026
Revvity USD 51.82M 11.1M Jun/2026
STAAR Surgical USD 8.06M 2.85M Jun/2026
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
Trinity Biotech USD -17.48M 12.34M Dec/2025
Waters USD -136M 64M Jun/2026